Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Ranpak Holdings exchange offer and consent solicitation
Davis Polk advised Ranpak Holdings Corp. in connection with an offer to exchange shares of Class A common stock of the…
Pague Menos R$746.9 million IPO
Davis Polk advised Empreendimentos Pague Menos S.A. (“Pague Menos”) in connection with its initial public offering of 87,873…
Pague Menos R$746.9 million IPO
Davis Polk advised Empreendimentos Pague Menos S.A. (“Pague Menos”) in connection with its initial public offering of 87,873…
Globe Life $50 million senior notes reopening
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Globe Life Inc. of $50…
Globe Life $50 million senior notes reopening
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Globe Life Inc. of $50…
Tencent Music $800 million debut SEC-registered notes offering
Davis Polk advised Tencent Music Entertainment Group on its debut SEC-registered notes offering, consisting of $300 million…
Tencent Music $800 million debut SEC-registered notes offering
Davis Polk advised Tencent Music Entertainment Group on its debut SEC-registered notes offering, consisting of $300 million…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate…
Emirate of Abu Dhabi $5 billion notes offering
Davis Polk advised the joint lead managers in connection with a Rule 144A/Regulation S offering by the Emirate of Abu Dhabi…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate…